4
Alkaloids; Supplement to Part 4 (Ed: J. E. Saxton), Wiley, New
York, 1994.
Chem. 2002, 45, 1949–1956. h) Liu, Y.; McWhorter Jr. W. W. J.
Org. Chem. 2003, 68, 2618–2622. i) Liu, Y.; McWhorter Jr. W. W.
J. Am. Chem. Soc. 2003, 125, 4240–4252. j) Movassaghi, M;
Schemidt, M. A.; Ashenhurst, J. A. Org. Lett. 2008, 10, 4009–4012.
k) Coldham, I.; Adams, H.; Ashweek, N. J.; Barker, T. A.; Reeder,
A. T.; Skilbeck, M. C. Tetrahedron Lett. 2010, 51, 2457–2460. l)
Guo, C.; Song, J.; Luo, S.–W.; Gong, L.–Z. Angew. Chem. Int. Ed.
2010, 49, 5558–5562. m) Kolundzic, F.; Noshi, M. N.; Tjandra, M.;
Movassaghi, M.; Miller, S. J. J. Am. Chem. Soc. 2011, 133, 9104–
9111.
2. a) Jenekhe, S. A.; Lu, L.; Alam, M. M. Macromolecules 2001, 34,
7315–7324. a) Tanabe, K.; Makimura, Y.; Tachi, Y.; Imagawa-sato,
A.; Nishimoto, S.–i. Bioorg. Med. Chem. Lett. 2005, 15, 2321–2324.
b) Tsai, M.–H.; Lin, H.–W.; Su, H.–C.; Ke, T.–H.; Fang, F.–C.;
Liao, Y.–L.; Wong, K.–T.; Wu, C.–I Adv. Mater 2006, 18, 1216–
1220. c) Watanabe, H.; Ono, M.; Haratake, M.; Kobashi, N.; Saji,
H.; Nakayama, M. Bioorg. Med. Chem. 2010, 18, 4740–4746. d)
Lee, C. W.; Lee, J. Y. Adv. Mater. 2013, 25, 5450–5454. e) Gorka,
A. P.; Nani, R. R.; Zhu, J.; Mackem, S.; Schnermann, M. J. J. Am.
Chem. Soc. 2014, 136, 14153–14159. f) Seki, Y.; Ishiyama, T.;
Sasaki, D.; Abe, J.; Sohma, Y.; Oisaki, K.; Kanai, M. J. Am. Chem.
Soc. 2016, 138, 10798–10801.
4. Beitzke, B.; Schmidt, R. R.; Chem. Ber. 1985, 118, 1726–1731.
5. Wang, Y.; Kong, C.; Du, Y.; Song, H.; Zhang, D.; Qin, Y. Org.
Biomol. Chem. 2012, 10, 2793–2797.
6. a) Tadano, S.; Mukaeda, Y.; Ishikawa, H. Angew. Chem. Int. Ed.
2013, 52, 7990–7994. b) Tadano, S.; Ishikawa, H. Synlett 2014, 25,
157–162. c) Tadano, S.; Sugimachi, Y.; Sumimoto, M.; Tsukamoto,
S.; Ishikawa, H.; Chem. Eur. J. 2016, 22, 1277–1291.
3. a) Witkop, B.; Ek, A. J. Am. Chem. Soc. 1951, 73, 5664–5669. b)
Evans, F. J.; Lyle, G. G.; Watkins, J.; Lyle, R. E.; J. Org. Chem.
1962, 27, 1553–1557. c) Williams, R. M.; Glinka, T.; Kwast, E.;
Coffman, H.; Stille, J. K. J. Am. Chem. Soc. 1990, 112, 808–821. d)
Stoermer, D.; Heathcock, C. H. J. Org. Chem. 1993, 58, 564–568. e)
Takayama, H.; Kurihara, M.; Subhadhirasakul, S.; Kitajima, M.;
Aimi, N.; Sakai. S. Heterocycles 1996, 42, 87–92. f) Kafka, S.;
Klásek, A.; Košmrlj, J. J. Org. Chem. 2001, 66, 6394–6399. g)
Takayama, H.; Ishikawa, H.; Kurihara, M.; Kitajima, M.; Aimi, N.;
Ponglux, D.; Koyama, F.; Matsumoto, K.; Moriyama, T.;
Yamamoto, L. T.; Watanabe, K.; Murayama, T.; Horie, S. J. Med.
7. Qin and co-workers reported that the coupling product at the C-2
position of the N-Me indole that connected the tryptophan C-3
position was obtained using their reported protocol. However, using
their reported protocol, we obtained the C-3 coupling product 5h as
the major product. The stereochemistry of 5h was determined by 2D
NMR and NOEDF analysis after removal of the Boc group (see
details in the Supporting Information).
Supplementary Material
Supplementary data associated with this article can be found, in
the online version, at http://